A DOSE FINDING STUDY WITH ZD1839 COMBINED WITH WEEKLY EPIDOXORUBICIN (EPI) AS SECOND-LINE THERAPY IN PATIENTS WITH ADVANCED BREAST CANCER (ABC)


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles